Emergence Therapeutics (private company)
See something wrong or missing? Let us know
Offices:Duisburg
Business model:B2B
Emergence Therapeutics is a European biopharmaceutical company developing novel antibody drug conjugate (ADC) immuno-therapeutics to treat high need cancers
Investors:
we tracked 10 investors
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
values in USD
Investments 99.27M
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
Companies with similar profile to Emergence Therapeutics
Name | Criteria | |
---|---|---|
![]() |
Beckley Psytech
70%
|
|
![]() |
CatalYm
70%
|
|
![]() |
NMD Pharma
70%
|
|
![]() |
Salvia BioElectronics
70%
|
|
![]() |
Sanifit Therapeutics
70%
|
|
![]() |
Synendos Therapeutics
70%
|
|
![]() |
Cytoki Pharma
70%
|
|
![]() |
Causaly
70%
|
|
![]() |
Eyevensys
70%
|
|
![]() |
Cardior Pharmaceuticals
70%
|
|